本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

35.98
+2.567.66%
盘前35.21-0.7700-2.14%04:08 EDT
成交量:183.54万
成交额:6,526.33万
市值:33.96亿
市盈率:-6.12
高:36.85
开:33.13
低:33.13
收:33.42
数据加载中...
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2020/01/09

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/18

重要事件披露

Current report, item 1.01
2019/11/25

重要事件披露

Current report, items 5.02 and 9.01
2019/11/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/10/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/04

重要事件披露

Current report, items 7.01, 8.01, and 9.01